|
|
Antihypertensive Agents
Research News and Information
Definition of 'Antihypertensive Agents'Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Common names: Antihypertensive Agents; Agents, Antihypertensive; Antihypertensives; Anti-Hypertensives; Anti Hypertensives; Antihypertensive Drugs; Drugs, Antihypertensive; Anti-Hypertensive Agents; Agents, Anti-Hypertensive; Anti Hypertensive Agents; Anti-Hypertensive Drugs; Anti Hypertensive Drugs |
Saturday, November 21, 2009
Outcomes of Ahmed glaucoma valve implantation in children with primary congenital glaucoma.
30 Oct 2009
OBJECTIVES: To evaluate the long-term efficacy of intraocular pressure reduction and complications of Ahmed glaucoma valve (AGV) implantation in children with primary congenital glaucoma. METHODS: The medical records of patients with primary ... Read more...
30 Oct 2009
The objective of this study was to assess the quality of antihypertensive drugs and to investigate the influence of tropical storage conditions. Drug content and in vitro dissolution tests were performed on 10 test formulations (from Rwanda) and 6 ... Read more...
30 Oct 2009
We describe a model for the essential role of the kidney in long-term blood pressure regulation. We begin with a simple hydraulic model for the circulation, with a constant circulating volume. We show, with the help of a modification of Guyton's ... Read more...
Latest indexed articles for 'Antihypertensive Agents'
These are the very latest articles for this heading:
- Asymptomatic spinal cord involvement in posterior reversible encephalopathy syndrome.
Nov 2009 - Outcomes of Ahmed glaucoma valve implantation in children with primary congenital glaucoma.
30 Oct 2009 - Influence of tropical climate conditions on the quality of antihypertensive drugs from Rwandan pharmacies.
30 Oct 2009 - The obligatory role of the kidney in long-term arterial blood pressure control: extending Guyton's model of the circulation.
30 Oct 2009 - A clinician's guide to the assessment and management of nonadherence in glaucoma.
30 Oct 2009 - Patient-centered communication to assess and enhance patient adherence to glaucoma medication.
30 Oct 2009 - A comprehensive perspective on patient adherence to topical glaucoma therapy.
30 Oct 2009 - Introduction: new insights on enhancing adherence to topical glaucoma medications.
30 Oct 2009 - ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses.
24 Oct 2009 - The potency of team-based care interventions for hypertension: a meta-analysis.
24 Oct 2009 - Blood-pressure control and delay in progression of kidney disease in children.
20 Oct 2009 - Strict blood-pressure control and progression of renal failure in children.
20 Oct 2009 - [Acute renal failure associated with malignant hypertension]
19 Oct 2009 - The editor's roundtable: prehypertension.
13 Oct 2009 - Mitral E wave deceleration time to peak E velocity ratio and cardiovascular outcome in hypertensive patients during antihypertensive treatment (from the LIFE echo-substudy).
13 Oct 2009 - Trends in medication use among US adults with diabetes mellitus: glycemic control at the expense of controlling cardiovascular risk factors.
10 Oct 2009 - Global disturbances in autonomic function yield cardiovascular instability and hypertension in the chromogranin a null mouse.
7 Oct 2009 - Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients.
3 Oct 2009 - Impact of nonadherence to antihypertensive therapy.
3 Oct 2009 - A novel measurement index for antihypertensive medication burden and its use.
3 Oct 2009
See a longer list of these articles.
Technical information about 'Antihypertensive Agents'
Definition: Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
Registry Number: 0
Descriptor UI: D000959
Alternative terms: Antihypertensive Agents; Agents, Antihypertensive; Antihypertensives; Anti-Hypertensives; Anti Hypertensives; Antihypertensive Drugs; Drugs, Antihypertensive; Anti-Hypertensive Agents; Agents, Anti-Hypertensive; Anti Hypertensive Agents; Anti-Hypertensive Drugs; Anti Hypertensive Drugs; Drugs, Anti-Hypertensive;
Related Mesh Headings: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Diuretics; Ganglionic Blockers; Vasodilator Agents;
Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;
Tree Number: D27.505.954.411.162;
Technical Notes: not for ocular hypertension